Stayble Therapeutics AB (publ) (FRA:4K4)

Germany flag Germany · Delayed Price · Currency is EUR
0.0161
-0.0001 (-0.62%)
Last updated: Feb 20, 2026, 3:25 PM CET
Market Cap1.12M -37.2%
Revenue (ttm)n/a
Net Income-761.30K
EPS-0.01
Shares Outn/a
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Average Volumen/a
Open0.0161
Previous Close0.0162
Day's Range0.0161 - 0.0161
52-Week Range0.0127 - 0.0528
Betan/a
RSI43.42
Earnings DateFeb 20, 2026

About Stayble Therapeutics AB

Stayble Therapeutics AB (publ) a clinical pharmaceutical company, developing an injection-based treatments for disc herniation. It develops STA363, an injection into the disc that targets chronic low back and leg pain. The company was incorporated in 2015 and is based in Gothenburg, Sweden. [Read more]

Industry Pharmaceutical Preparations
Founded 2015
Employees 2
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol 4K4
Full Company Profile

Financial Performance

Financial numbers in SEK Financial Statements